Medical Device Determines Cardiac Risk Using T-wave Repolarization Measurements
Summary
USPTO published patent application US20260091236A1 by inventors Hernandez and De Groot for a medical device and method that determines cardiac event risk using T-wave repolarization measurements. The device derives T-wave loops from up to two cardiac electrical signals and determines metrics of changes in repolarization measurements to assess cardiac risk.
What changed
Patent application US20260091236A1 discloses a medical device configured to receive up to two cardiac electrical signals and derive T-wave loops in at least two dimensions for each cardiac cycle. The device determines repolarization measurements representative of each T-wave loop, calculates changes from previously determined measurements, and derives metrics of those changes to assess cardiac event risk. The invention is classified under CPC codes A61N 1/365 and G16H 50/30.
Patent applications do not create immediate compliance obligations or deadlines. Medical device manufacturers and developers in cardiac monitoring technology may review this filing to understand the scope of claimed subject matter and assess potential freedom-to-operate considerations. No regulatory action is required at this time.
Archived snapshot
Apr 2, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
MEDICAL DEVICE AND METHOD FOR DETERMINING RISK OF A CARDIAC EVENT
Application US20260091236A1 Kind: A1 Apr 02, 2026
Inventors
Alfonso ARANDA HERNANDEZ, Paul J. DEGROOT
Abstract
A medical device is configured to receive up to two cardiac electrical signals. For each cardiac cycle of multiple cardiac cycles, the device may derive a T-wave loop in at least two dimensions using one or two of the up to two cardiac electrical signals. The medical device may determine a repolarization measurement representative of each T-wave loop and determine a change in the repolarization measurement from a previously determined repolarization measurement. The device may determine a metric of the determined changes in the repolarization measurements.
CPC Classifications
A61N 1/365 G16H 50/30
Filing Date
2023-09-13
Application No.
19112241
Related changes
Get daily alerts for USPTO Patent Applications - Health Informatics (G16H)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Health Informatics (G16H) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.